Losartan-induced hepatic injury.
Explore this paper's citation graph
Summary
A case of severe hepatic toxicity and fibrosis caused by losartan use is reported, and the clinician should be aware of this toxicity, especially during the initial phase of treatment.
- Type
- review
- Published
- 2002-05-01
- Cited by
- 42
- References
- 13
- OpenAlex
- https://openalex.org/W2034410891
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:53669
Keywords
Losartan, Medicine, Toxicity, Angiotensin II, Angiotensin II receptor antagonist
References
- Criteria of drug-induced liver disorders. Report of an international consensus meeting.
- Marked hepatotoxicity associated with losartan treatment.
- Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
- Comment: Glucosamine: Selecting Appropriate Study Exclusion Criteria
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
- Losartan-induced hepatotoxicity.
- Losartan: First of a New Class of Angiotensin Antagonists for the Management of Hypertension
- Angiotensin II receptor inhibition. A new therapeutic principle.
- The natural history of histologically proved drug induced liver disease
- Drug-induced hepatotoxicity.
- Angiotensin II Receptor Antagonists: The Prototype Losartan
- Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
- Angiotensin II receptor inhibition. A new therapeutic principle
- Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components
- Losartan-induced hepatotoxicity
Cited by
- Azathioprine induced cholestatic hepatitis
- Drug-induced liver injury
- Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review
- Candesartan cilexetil-induced severe hepatotoxicity.
- Traveler's Constipation
- The Administration of Gliadin Downregulates the Intraepithelial Lymphocytosis Induced by a Rectal Gluten Challenge
- Renal diseases and the liver.
- Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.
- Angiotensin II Protects Primary Rat Hepatocytes against Bile Salt-Induced Apoptosis
- Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease
- Clinical Pharmacokinetics of Losartan
- CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
- Drugs and non-alcoholic steatohepatitis
- Effect on Hepatic Parameters and Hepatocytes following administration of antihypertensive, hypolipidemic and hypoglycemic drugs in combination (Part II)
- Hépatotoxicité liée à l’irbésartan : à propos d’un cas
- Patient with drug-induced hepatic injury caused by long-term administration of an angiotesin II receptor antagonist, losartan
- This month in APR
- Signal transduction pathways in hepatocyte cell death : new targets for therapy
- Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers
- Losartan-induced Severe Hepatic Injury: A Case Report and Literature Review
Related papers
- Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
- The hyperglycemia induced by angiotensin II in rats is mediated by AT1 receptors.
- Delayed recovery of hypertension after single dose losartan in angiotensin II-infused conscious rats.
- Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
- Comparative Cardiovascular Effects of the Angiotensin II Type 1 Receptor Antagonists ZD 7155 and Losartan in the Rat
- Effects of U‐97018 on Pressor Responses to Intracerebroventricularly Administered Angiotensin II in Conscious Normotensive Rats
- Candesartan, an Insurmountable Antagonist of Angiotensin II-mediated Contractile Effects in Isolated Vascular Preparations: Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174)
- Intracerebroventricular injection of losartan inhibits angiotensin II-sensitive neurons via GABA inputs in the anterior hypothalamic area of rats.
- Angiotensin II-induced suppression of alcohol intake and its reversal by the angiotensin antagonist Sar-1 Thr-8 angiotensin II.